

Publisher: John Wiley & Sons Inc
E-ISSN: 1096-9098|111|5|641-645
ISSN: 0022-4790
Source: JOURNAL OF SURGICAL ONCOLOGY, Vol.111, Iss.5, 2015-04, pp. : 641-645
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




Patient‐reported outcomes enhance understanding of the impact of pazopanib in soft tissue sarcoma
CANCER, Vol. 121, Iss. 17, 2015-09 ,pp. :




Chemotherapy for soft tissue sarcoma
CANCER, Vol. 122, Iss. 19, 2016-10 ,pp. :


CANCER, Vol. 120, Iss. 19, 2014-10 ,pp. :